Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
In 2012, the New England Compounding Center in Framingham, Massachusetts, created a run of injectable steroids for patients across the US
96401/96402 for Chemotherapy and Hormonal Agents The most critical code-selection rule for procedure code 96372 is confirming that the drug administered is not a chemotherapy or hormonal antineoplastic agent: Non-hormonal chemotherapy agents (e.g., methotrexate for cancer, bleomycin) administered SC or IM CPT 96401 , not 96372 CPT code Hormonal antineoplastic agents (e.g., leuprolide acetate/Lupron, goserelin/Zoladex, degarelix) administered SC or IM CPT 96402 , not procedure code 96372 Note that methotrexate administered for rheumatoid arthritis or psoriasis (not cancer) may be reported under CPT code 96372 since it is used in that context as an immunosuppressant rather than a chemotherapy agent
Peptides reach peak blood levels more quickly, which may be advantageous for certain research applications
Confirmatory secondary endpoints included 20%, 25%, and 30% weight loss, with all analyses performed on an intention-to-treat basis and reported with 95% confidence intervals
Common side effects are mild injectionsite reactions
US$ 26.16
US$ 22.16
US$ 23.52
US$ 20.23
